Ishares Msci Brazil ETF vs Intuitive Surgical, Inc. — how do they compare? Ishares Msci Brazil ETF trades at $43.54 (market cap $11.30B), while Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 13× Ishares Msci Brazil ETF's market cap, and Ishares Msci Brazil ETF is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ishares Msci Brazil ETF for 50 Days and Intuitive Surgical, Inc. for 84 Days on average.
| EWZ | ISRG | |
|---|---|---|
Market Cap | $11.30B | $146.76B |
Volume | 44,036,597 | 2,529,814 |
Sector | Broad Market / Factor | Health |
52-Week High | $43.54 | $592.85 |
52-Week Low | $28.79 | $332.02 |
Typical Hold Time | 50 Days | 84 Days |
Enterprise Value | — | $141.54B |
Signals from Pluang's Aura AI — not financial advice
EWZ, the iShares MSCI Brazil ETF, trades at $42.59, up 0.52% today, with a bullish technical signal from moving averages but overbought RSI readings. The ETF is heavily influenced by Brazil's upcoming October 2026 election, with institutional investors accumulating call options betting on a favorable outcome. Recent news highlights EWZ as a diversifier from U.S. tech exposure, though it faces competition from lower-fee alternatives like FLBR.
The outlook for EWZ hinges on Brazil's election result and commodity trends, offering asymmetric upside if pro-market policies prevail. Key risks include political volatility, U.S. tariff impacts, and currency fluctuations. Wall Street sentiment is cautiously optimistic, with unusual options activity signaling speculative interest in near-term gains.
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% with a bullish technical outlook. The stock shows strong fundamentals with 2025 revenue of $10.06B and net income of $2.86B, maintaining consistent earnings beats. Valuation metrics remain elevated with a P/E of 47.64 and P/S of 13.54, reflecting premium pricing for the robotic surgery leader. Recent news highlights international expansion in India and Japan to offset China weakness, while da Vinci 5 upgrades and ASC market penetration drive growth.
ISRG presents a compelling growth story with dominant market position and expanding global footprint, though premium valuation requires sustained execution. Key risks include procedure growth moderation and competitive pressures. Analyst consensus remains strongly bullish with $480.78 price target representing 16% upside potential from current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →